Results

Total Results: 334 records

Showing results for "phase".

201. Archived: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
     October 15, 2009 - a risk marker in the general population and against the use of other inflammatory markers or acute-phase

202. Archived: Obesity: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-screening-1996
     January 01, 1996 - Weight loss intervention in phase 1 of the Trials of Hypertension Prevention.

203. N3Veybr4Zdhzfqsw3Erlhe (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
     November 01, 2014 - Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase

204. Recommendation: Prevention of Child Maltreatment: Primary Care Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/child-maltreatment-primary-care-interventions
     March 19, 2024 - Phase II; Board on Children, Youth, and Families; Committee on Law and Justice; Institute of Medicine

205. Primary Care Interventions to Prevent Child Maltreatment: US Preventive Services Task Force Recommendaiton Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/PR7HUFdx2b_F9HvDFqz76L
     March 19, 2024 - Phase II; Board on Children, Youth, and Families; Committee on Law and Justice; Institute of Medicine

206. Evidence Summary: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
     January 19, 2021 - of e-cigarettes was high at 6- and 12-month follow-up (approximately 3-9 months after the treatment phase … at 6- to 12-mo follow-up, although continued use of e-cigarettes remained high after the treatment phase

207. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. … A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users

208. Archived: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening
     June 15, 2008 - evidence that available screening tests accurately detect type 2 diabetes during an early, asymptomatic phase

209. Archived: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening-2008
     June 15, 2008 - evidence that available screening tests accurately detect type 2 diabetes during an early, asymptomatic phase

210. 827Cwgymvawpvovg Syjpf (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/827CwGYMVawpVoVg_syJpF
     October 01, 2015 - Also, serum ferritin is an acute phase reactant, which means its levels increase during periods of inflammation

211. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
     September 03, 2019 - Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. … A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users

212. Evidence Summary: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening
     June 26, 2018 - Liberman UA, Weiss SR, Bröll J, et al; Alendronate Phase III Osteoporosis Treatment Study Group. … osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase

213. Archived: Evidence Summary: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
     June 26, 2018 - Liberman UA, Weiss SR, Bröll J, et al; Alendronate Phase III Osteoporosis Treatment Study Group. … osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase

214. Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/decision-modeling-for-uspstf_0.pdf
     July 01, 2016 - answered in the early stages of planning when feasible, ideally dur- ing the research plan development phase

215. Interventions for Tobacco Cessation in Adults, Including Pregnant Persons: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/eSLqaKpvzhYRbQVeumNgSQ
     January 19, 2021 - of e-cigarettes was high at 6- and 12-month follow-up (approximately 3-9 months after the treatment phase … at 6- to 12-mo follow-up, although continued use of e-cigarettes remained high after the treatment phase

216. Assessing Algorithmic Bias and Fairness in Clinical Prediction Models for Preventive Services: A Health Equity Methods Project for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/assessing-algorithmic-bias-fairness_0.pdf
     August 16, 2023 - bias have been assessed in a more technical and less normative sense during the evidence synthesis phase

217. Primary Care–Relevant Interventions to Prevent Opioid Use Disorder: Current Research and Evidence Gaps (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/prevention-of-opioid-user-disorder-ehc-tech-brief.pdf
     May 14, 2021 - drug use among children, adolescents, and young adults before they ever try drugs (in the abstinence phase … Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase

218. 85-Vhmwwoglhd8Mvajt6Gq (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/85-VHmWWogLhD8mvajT6gq
     April 01, 2015 - As an acute-phase reactant, serum ferritin can be elevated in inflammatory conditions and may be of limited … However, both of these studies ended the placebo phase of the trial at 28 weeks' gestation, after which

219. Szn5Hhs8W5Sar6Bbpabsab (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/sZN5HHS8w5Sar6bBPabsaB
     June 01, 2008 - Diabetes has a long preclinical phase, estimated at 10 to 12 years on the basis of the progression of … We also need studies to define the duration of the prediabetes phase and identify measur- able risk factors

220. Archived: Final Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
     June 15, 2008 - Diabetes has a long preclinical phase, estimated at 10 to 12 years on the basis of the progression of … We also need studies to define the duration of the prediabetes phase and identify measurable risk factors